Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts.
Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
JAMA Cardiol. 2018 Jun 1;3(6):455-462. doi: 10.1001/jamacardio.2018.1042.
The neutrophil-to-lymphocyte ratio (NLR) is associated with mortality and cardiovascular disease at the time of incident disease, but it is not known whether this is true in prospective studies. Further, a common genetic variant of African origin associated with a relative neutropenia, the Duffy antigen variant, is a candidate to modify associations between NLR and outcomes.
To investigate the association between NLR and mortality and cardiovascular-related outcomes in the Jackson Heart Study (JHS) and validated our findings in the Normative Aging Study (NAS). We also evaluated whether the Duffy antigen variant modifies these associations in the JHS.
DESIGN, SETTING, AND PARTICIPANTS: The JHS is a large prospective cohort study designed to examine risk factors and cardiovascular disease among African American individuals residing in Jackson, Mississippi. The NAS is a longitudinal cohort established by the United States Department of Veterans Affairs in 1963. The JHS is a population-based longitudinal study. The NAS is an interdisciplinary longitudinal study located in the Veterans Affairs Outpatient Clinic in Boston, Massachusetts. A total of 5301 participants were recruited for the JHS at baseline. Genotype data on the Duffy antigen variant were available in the JHS. The participants in the NAS were white men only and free of chronic disease at the time of recruitment and were invited for in-person examinations every 3 years since 1986. Data were analyzed between November 2016 and January 2018.
All-cause mortality, coronary heart disease (CHD), stroke, and heart failure (HF). Two NLR cutoff values (≥2.15 for overall and ≥1.77 for African American participants) were used as the exposure measurements.
The participants were African American men and women, aged 21 to 93 years, residing in Jackson, Mississippi. For NLR <2.15, the mean age was 54.2 (12.5); for NLR >2.15, the mean age was 56.5 (13.8); for NLR <1.77, the mean age is 54.1 (12.4); and for NLR >1.77, the mean age was 55.8 (13.6). Adjusting for potential confounders, elevated NLR (≥2.15) was significantly associated with an increased risk for all-cause mortality (hazard ratio, 1.40; 95% CI, 1.14-1.70) and CHD (hazard ratio, 1.69; 95% CI, 1.23-2.34) in JHS. Using a lower NLR cutoff (≥1.77) for African American participants did not alter the significant associations. In the NAS, elevated NLR was associated with an increased risk of mortality (hazard ratio, 1.32; 95% CI, 0.99-1.76), with no statistical significance. In both prospective studies, NLR was less of a robust predictor when the time of event was more distant. The Duffy antigen variant was associated with neutrophil count, and NLR (≥1.77) was significantly associated with mortality, CHD, stroke, and HF in the Duffy antigen-negative group.
Neutrophil-to-lymphocyte ratio was prospectively associated with all-cause mortality, CHD, and HF, with closer median time to event diagnoses in the JHS. Furthermore, the Duffy antigen variant locus was associated with a lower baseline NLR and modified the mortality, CHD, stroke, and HF associations.
中性粒细胞与淋巴细胞比值(NLR)与疾病发病时的死亡率和心血管疾病相关,但在前瞻性研究中尚不清楚这是否正确。此外,与相对中性粒细胞减少相关的常见非洲起源的遗传变异,即达菲抗原变异体,是一种候选因子,可以改变 NLR 与结局之间的关联。
在杰克逊心脏研究(JHS)中调查 NLR 与死亡率和心血管相关结局之间的关系,并在正态老化研究(NAS)中验证我们的发现。我们还评估了达菲抗原变异体是否在 JHS 中改变了这些关联。
设计、地点和参与者:JHS 是一项大型前瞻性队列研究,旨在检查非洲裔美国人中与风险因素和心血管疾病相关的问题。NAS 是由美国退伍军人事务部于 1963 年建立的一个纵向队列。JHS 是一项基于人群的纵向研究。NAS 是位于马萨诸塞州波士顿退伍军人事务门诊的一项跨学科纵向研究。共有 5301 名参与者在基线时被招募到 JHS。JHS 中可用达菲抗原变异体的基因型数据。NAS 的参与者均为白人男性,在招募时没有慢性疾病,并自 1986 年以来每 3 年邀请他们进行一次体检。数据分析于 2016 年 11 月至 2018 年 1 月进行。
全因死亡率、冠心病(CHD)、中风和心力衰竭(HF)。使用两个 NLR 截断值(NLR <2.15 时为≥2.15,NLR >2.15 时为≥1.77)作为暴露测量值。
参与者为居住在密西西比州杰克逊的 21 至 93 岁的非裔美国男性和女性。对于 NLR <2.15,平均年龄为 54.2(12.5);对于 NLR >2.15,平均年龄为 56.5(13.8);对于 NLR <1.77,平均年龄为 54.1(12.4);对于 NLR >1.77,平均年龄为 55.8(13.6)。在调整潜在混杂因素后,升高的 NLR(≥2.15)与全因死亡率(危险比,1.40;95%CI,1.14-1.70)和 CHD(危险比,1.69;95%CI,1.23-2.34)的风险显著增加相关在 JHS 中。对于非洲裔美国参与者使用较低的 NLR 截断值(≥1.77)并没有改变显著的关联。在 NAS 中,升高的 NLR 与死亡率风险增加相关(危险比,1.32;95%CI,0.99-1.76),但无统计学意义。在这两项前瞻性研究中,当事件时间较遥远时,NLR 的预测能力较弱。达菲抗原变异体与中性粒细胞计数相关,NLR(≥1.77)与达菲抗原阴性组的死亡率、CHD、中风和 HF 显著相关。
NLR 与全因死亡率、CHD 和 HF 呈前瞻性相关,在 JHS 中与事件诊断的中位时间更接近。此外,达菲抗原变异体的位置与较低的基线 NLR 相关,并改变了死亡率、CHD、中风和 HF 的关联。